Banking
UBS has identified Barclays as a notable banking-sector opportunity, maintaining its Buy rating and assigning a 12-month price target of 600 pence. The assessment comes as U.S. banks provide mixed signals on third-quarter trading and dealmaking, while Barclays has not issued its customary third-quarter trading update.
The central issue for investors is the combination of Barclays’ valuation, earnings trajectory and planned investment in future cost reductions.
Barclays closed at 470 pence on September 15, according to the source. UBS’ 600-pence target therefore represents approximately 28% potential share-price appreciation from that level, or roughly 31% when dividends are included.
The valuation gap cited by UBS is particularly notable. Barclays trades at approximately 7.2 times forecast 2027 earnings, compared with 13.9 times for Goldman Sachs, 14.2 times for JPMorgan and 15 times for Morgan Stanley.
The comparison does not by itself establish that the valuation gap will close. The multiples reflect different business mixes, earnings expectations and risk assumptions. For wealth investors, however, the dispersion provides a useful framework for examining how the market values Barclays relative to major investment-banking peers.
UBS’ assessment comes as major U.S. banks provide differing indications regarding trading and investment-banking activity.
Bank of America indicated that sales and trading revenue was expected to be broadly flat, while investment-banking fees were projected at approximately $1.6 billion to $1.8 billion, representing a decline of around 17% year over year.
Citigroup provided guidance for mid-single-digit growth in markets revenue, while JPMorgan expected trading and banking income to increase by the mid-to-high teens.
These differing outlooks demonstrate why quarter-to-quarter investment-banking revenue can be difficult to extrapolate. Barclays, following its usual practice cited in the source, did not provide a third-quarter trading update.
UBS argued that Barclays is less exposed to quarterly fluctuations in investment-banking activity than its share price might suggest.
This distinction is relevant because investment banking and markets businesses can experience significant changes in revenue from one quarter to another depending on deal volumes, capital-markets activity, trading conditions and market volatility.
A broader earnings mix can potentially reduce the direct effect of a weaker quarter in any individual business. However, the source does not provide a detailed breakdown quantifying Barclays’ current sensitivity to investment-banking revenue.
One of the more significant elements of UBS’ analysis concerns Barclays’ planned spending on cost-reduction measures.
The bank plans to spend an additional £600 million to £650 million during the second half compared with the first half on initiatives designed to reduce future costs.
UBS estimates that these measures could provide a cushion of up to £1 billion against 2027 profit if investment-banking income declines.
The distinction between current expenditure and future savings is important. Barclays is accepting additional near-term costs in pursuit of lower expenses later, making execution and realization of those savings critical to the investment case.
UBS’ analysis effectively links Barclays’ low valuation multiple with its expectations for faster profit growth and future cost efficiency.
For HNWIs, the relevant question is not simply whether Barclays trades at a discount to U.S. peers, but why that discount exists and whether the underlying factors are changing.
The bank’s future valuation will depend on its ability to deliver sustainable earnings, control expenses and maintain capital returns while navigating changes in investment-banking activity and the broader UK financial environment.
Barclays enters the current period with a valuation substantially below the U.S. banking multiples cited by UBS, while its planned cost-reduction investment creates a potential earnings benefit beyond the current financial year.
The external environment remains mixed. Divergent third-quarter guidance from major U.S. banks illustrates the uncertainty surrounding markets and investment-banking revenue, while Barclays has chosen not to provide a third-quarter trading update.
For global wealth portfolios, the key indicators are therefore cost execution, investment-banking volumes, markets revenue, capital generation and the extent to which planned efficiencies translate into sustainable earnings improvement.
UBS has maintained its Buy rating on Barclays and set a 600-pence 12-month price target against the bank’s 470-pence September 15 close. The analysis centers on Barclays’ relatively low 7.2-times forecast 2027 earnings multiple and its planned £600 million to £650 million of additional second-half spending on cost-reduction initiatives. UBS estimates those measures could provide up to £1 billion of protection to 2027 profit if investment-banking income weakens. For sophisticated investors, the critical test will be whether cost savings and earnings growth can translate into durable improvements in profitability while the bank navigates cyclical markets and dealmaking conditions.
For a confidential discussion regarding retail banking strategy, insurance distribution models, customer loyalty ecosystems, digital financial services, or cross-border financial innovation opportunities, contact our senior advisory team.
September 17, 2026
September 16, 2026
September 16, 2026
September 16, 2026